首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1419125

消融设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按设备、应用程式、最终用户和地理位置

Ablation Device Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Device, Application, End-User, and Geography

出版日期: 2023年11月22日 | 出版商:

The Insight Partners | 英文 185 Pages | 商品交期: 1-5个工作天内

价格

简介目录

全球消融器械市场预计将从2022年的83.25亿美元增加到2030年的160.20亿美元。预计2022年至2030年该市场将以8.5%的CAGR成长。

推动市场成长的关键因素包括慢性病盛行率的上升、老年人口的增加以及对微创手术的需求不断增加。然而，替代治疗方法和疗法的强势地位阻碍了市场成长。

消融设备市场的市场驱动因素

全球对微创手术的需求持续成长。与传统开放性手术相比，微创手术有几个优点，包括切口较小、恢復时间较短、疼痛减轻和併发症风险较低。先进技术用于微创治疗，以识别和管理包括癌症在内的各种疾病。这些技术已被用来去除癌症肿瘤和淋巴结，且不会留下任何疤痕。外科医生还可以使用微创手术采集组织进行活检和精确的分期测试。这使得外科医生能够设计出精确的癌症治疗方案。

此外，根据加州大学旧金山分校放射与生物医学影像系的说法，如果小肾肿瘤尚未扩散到肾臟之外，那么肾肿瘤的微波消融（MWA）和射频消融（RFA）是手术切除的实用替代方案。 MWA 和 RFA 是微创、非手术治疗，恢復时间不到 24 小时。因此，消融装置透过各种能量方式提供精确的组织破坏，在微创手术中发挥着至关重要的作用，从而推动了对消融装置的需求。因此，对微创手术的需求推动了消融设备市场的成长。

阻碍消融设备市场的因素

消融技术面临其他治疗方法的竞争，包括手术介入、放射治疗、全身性药物治疗和其他微创手术。根据所治疗的特定病情，医疗保健提供者可能会根据疗效、安全性、患者资格、成本效益或资源可用性等因素选择替代治疗方式。替代治疗方案的可用性和偏好可能会限制消融装置的采用和使用。例如，由于大众对传统癌症治疗的认识较高，发展中国家对先进治疗方案的采用率较低，以及外科医生不愿放弃传统治疗方案，因此手术、化疗和放射治疗等治疗方法是癌症治疗的首选方法。因此，上述因素阻碍了消融装置市场的成长。

消融设备市场：细分概述

消融设备市场依设备分为射频设备、雷射/光消融设备、超音波设备、冷冻消融设备等。射频设备细分市场在 2022 年占据更大的市场份额，预计该细分市场在 2022 年至 2030 年期间将实现更高的CAGR。射频消融术是一种微创手术，用于治疗肌瘤、骨骼、组织、甲状腺、子宫内膜、静脉曲张等。它是传统外科手术的替代方案。

消融设备市场按应用细分为癌症治疗、心血管疾病治疗、眼科治疗、妇科治疗、泌尿科治疗、美容外科等。 2022年，心血管疾病治疗领域占有更大的市场份额；此外，预计同一细分市场在 2022 年至 2030 年期间将出现更高的CAGR。

依最终用户划分，消融设备市场分为医院和诊所、门诊手术中心等。 2022年，医院和诊所细分市场占据最大的市场份额，预计该细分市场在2022年至2030年期间复合CAGR最高。医院和诊所是消融设备的主要最终用户，因为它们提供广泛的医疗服务，包括需要消融的非侵入性手术。

消融设备市场：地理概况

据估计，2022 年至 2030 年亚太地区的CAGR最高。印度和中国等亚太国家拥有消融设备市场的巨大成长潜力。该地区的发展中国家改善了医疗基础设施，增加了医疗支出，并越来越注重采用先进的医疗技术，为市场扩张提供了机会。随着新兴市场对医疗保健基础设施的投资以及越来越多的医生接触先进的消融技术，对消融设备的需求将会增加，从而推动亚太地区的市场成长。

2022年，北美在全球消融设备市场规模中占据最大份额。美国的癌症发生率很高，这推动了消融设备市场的成长。根据美国癌症协会估计，2021年有超过190万人被诊断出罹患癌症，608,570人因癌症死亡。另据报导，在美国，有二分之一的男性和三分之一的女性在一生中会被诊断出罹患癌症。因此，美国癌症的高盛行率推动了消融设备市场的成长。

此外，根据美国医疗保险和医疗补助服务中心的数据，2021年美国国家医疗保健支出成长2.7%，达到4.3兆美元，即人均12,914美元。此外，医疗支出占国内生产毛额的18.3%。此外，根据美国卫生与公众服务部的数据，2019年至2028年，国家卫生支出预计将以每年平均5.4%的速度成长，到2028年预计将达到6.2兆美元。增加与药物开发相关的研究的各种资金，刺激研究和学术机构对消融设备的需求。

A few of the major primary and secondary sources referred to while preparing the report on the ablation device market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界卫生组织).

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第 12 章：竞争格局

关键参与者的热图分析
公司定位与专注

第 13 章：消融设备市场 - 主要公司概况

Abbott

注意 - 将为以下公司列表提供类似信息

美敦力
波士顿科学公司
康迈德公司
血管动力学
史密斯和侄子
奥林巴斯
Galil Medical Inc.（被 BTG International Ltd 收购）
Ethicon US, LLC（强生公司的子公司）
史赛克

第 14 章：附录

词彙表
关于 Insight Partners
市场情报云

简介目录

Product Code: TIPRE00003095

The global ablation device market is expected to reach US$ 16.020 billion in 2030 from US$ 8.325 billion in 2022. The market is estimated to grow with a CAGR of 8.5% from 2022 to 2030.

The key factors driving the market's growth include the growing prevalence of chronic diseases, an increase in the geriatric population, and increasing demand for minimally invasive procedures. However, the strong position of alternative treatment methods and therapies hinders market growth.

Market Drivers of the Ablation Device Market

The demand for minimally invasive surgeries continues to rise globally. Minimally invasive procedures have several advantages over traditional open surgeries, including smaller incisions, shorter recovery time, reduced pain, and lower risk of complications. Advanced technology is used in minimally invasive treatments for the identification and management of a variety of disorders, including cancer. These techniques have been implemented to remove cancer tumors and lymph nodes without any scars. Surgeons can also use minimally invasive procedures to harvest tissues for biopsy and precise staging tests. This enables surgeons to devise precise cancer therapy programs.

Furthermore, according to the UCSF Department of Radiology & Biomedical Imaging, if the small renal tumors have not spread beyond the kidney, then microwave ablation (MWA) and radiofrequency ablation (RFA) of kidney tumors are practical alternatives to surgical resection. MWA and RFA are minimally invasive, non-surgical procedures with a recovery time of less than 24 hours. Thus, ablation devices play a crucial role in enabling minimally invasive surgeries by offering precise tissue destruction through various energy modalities, thereby driving the demand for ablation devices. Thus, the demand for minimally invasive surgeries fuels the ablation device market growth.

Factors Hampering the Ablation Device Market

ablation techniques face competition from alternative treatment methods, including surgical interventions, radiation therapy, systemic drug therapies, and other minimally invasive procedures. Depending on the specific condition being treated, healthcare providers may opt for alternative treatment modalities based on factors such as efficacy, safety profile, patient eligibility, cost-effectiveness, or availability of resources. The availability and preference for alternative treatment options can limit the adoption and utilization of ablation devices. For example, treatment methods such as surgery, chemotherapy, and radiation therapy are preferred in cancer treatment due to high public awareness of traditional cancer treatments, low adoption of advanced treatment options in developing countries, and surgeons' reluctance to abandon traditional treatment options. Thus, the factors mentioned hamper the growth of the ablation device market.

Ablation Device Market: Segmental Overview

The ablation device market, by device, is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. The radiofrequency devices segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030. Radiofrequency ablation is a minimally invasive procedure used in the treatment of myomas, bones, tissues, thyroid, endometrium, varicose veins, and others. It is an alternative to the traditional surgical operation.

The ablation device market, by application, is segmented into cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. The cardiovascular disease treatment segment held a larger market share in 2022; also, the same segment is anticipated to register a higher CAGR during 2022-2030.

The ablation device market, by end users, is segmented into hospitals and clinics, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022-2030. Hospitals and clinics are the primary end users of ablation devices as they offer a wide range of medical services, including non-invasive procedures that require ablation.

Ablation Device Market: Geographical Overview

Asia Pacific is estimated to register the highest CAGR during 2022-2030. Countries in the Asia Pacific, such as India and China, hold significant potential for the growth of the ablation devices market. Developing countries in the region with improving healthcare infrastructure, increasing healthcare expenditure, and a rising focus on adopting advanced medical technologies offer opportunities for market expansion. As emerging markets invest in healthcare infrastructure and as more physicians gain exposure to advanced ablation techniques, the demand for ablation devices will increase, boosting the market growth in Asia Pacific.

In 2022, North America held the largest share of the global ablation device market size. The US has a high prevalence of cancer cases, which propels the ablation device market growth. As per the American Cancer Society estimates, more than 1.9 million people were diagnosed with cancer in 2021, and 608,570 people died due to cancer. It is also reported that 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime in the US. Thus, the high prevalence of cancer among people in the US fuels the ablation device market growth.

Furthermore, according to the US Centers for Medicare & Medicaid Services, the national healthcare expenditure in the US increased by 2.7 percent in 2021, reaching US$ 4.3 trillion or US$ 12,914 per person. Also, health spending accounted for 18.3 percent of the nation's Gross Domestic Product. Furthermore, according to the US Department of Health & Human Services, National health spending is expected to grow at a 5.4% annual rate from 2019 to 2028, and it is expected to reach US$ 6.2 trillion by 2028. The rising health expenditure is estimated to increase various funding in the research related to the development of drugs, fueling the demand for ablation device by research and academic institutes.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Ablation Device Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Ablation Device Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Ablation Device Market - Global Market Analysis

6.1 Ablation Device - Global Market Overview
6.2 Ablation Device - Global Market and Forecast to 2030

7. Ablation Device Market - Revenue Analysis (USD Million) - By Product, 2020-2030

7.1 Overview
7.2 Laser/Light Devices
7.3 Radiofrequency Devices
7.4 Ultrasound Devices
7.5 Cryoablation Devices
7.6 Others

8. Ablation Device Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Cancer Treatment
8.3 Cosmetic Surgery
8.4 Urological Treatment
8.5 Cardiovascular Treatment
8.6 Ophthalmologic Treatment
8.7 Gynecological Treatment
8.8 Others

9. Ablation Device Market - Revenue Analysis (USD Million) - By End Users, 2020-2030

9.1 Overview
9.2 Hospitals and Clinics
9.3 Ambulatory Surgical Centers (ASCs)
9.4 Others

10. Ablation Device Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Ablation Device Market Overview
- 10.1.2 North America Ablation Device Market Revenue and Forecasts to 2030
- 10.1.3 North America Ablation Device Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Ablation Device Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Ablation Device Market Revenue and Forecasts and Analysis - By End Users
- 10.1.6 North America Ablation Device Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Ablation Device Market
    - 10.1.6.1.1 United States Ablation Device Market, by Product
    - 10.1.6.1.2 United States Ablation Device Market, by Application
    - 10.1.6.1.3 United States Ablation Device Market, by End Users
  - 10.1.6.2 Canada Ablation Device Market
    - 10.1.6.2.1 Canada Ablation Device Market, by Product
    - 10.1.6.2.2 Canada Ablation Device Market, by Application
    - 10.1.6.2.3 Canada Ablation Device Market, by End Users
  - 10.1.6.3 Mexico Ablation Device Market
    - 10.1.6.3.1 Mexico Ablation Device Market, by Product
    - 10.1.6.3.2 Mexico Ablation Device Market, by Application
    - 10.1.6.3.3 Mexico Ablation Device Market, by End Users

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

12. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

13. Ablation Device Market - Key Company Profiles

14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies